Hyundai Mobis confirmed the two companies have agreed to jointly develop a new ‘Holographic Windshield Display' ...

We believe Carl Zeiss Meditec is in excellent financial health. At the end of fiscal-year 2023, the company had a cash and equivalents balance of 880 million euros with little to no debt.

Winner of the 2023 Optician Awards Lens Award, Carl Zeiss Vision, speaks to Emma White about sustainability, product ...

Most readers would already be aware that Carl Zeiss Meditec's (ETR:AFX) stock increased significantly by 19% over ...

Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices, or OPT, and microsurgery, or MCS. OPT makes up roughly 75% ...

Carl Zeiss Meditec AG (ETR:AFX), is not the largest company out there, but it led the XTRA gainers with a relatively large price hike in the past couple of weeks. Shareholders may appreciate the ...

With the KINEVO 900 S, ZEISS has raised the bar for state-of-the-art operating microscopes for neurosurgery." In 2017, the ...

ZEISS VisioGen offers a cutting-edge, AI-driven solution designed to enhance refractive patient communication and streamline ...

ZEISS VisioGen offers a cutting-edge, AI-driven solution designed to enhance refractive patient communication and streamline ...

Carl Zeiss Meditec appears to be overvalued by 25% at the moment, based on our discounted cash flow valuation. The stock is currently priced at €70.85 on the market compared to our intrinsic value of ...